Merck Signs Two Oncology Collaborations with Seattle Genetics

By Michelle Liu

Pharma Deals Review: Vol 2020 Issue 9 (Table of Contents)

Published: 21 Sep-2020

DOI: 10.3833/pdr.v2020.i9.2563     ISSN: 1756-7874

Section: Research & Development



Cementing its interest inantibody-drug conjugate technology, Merck & Co...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details